Clinical Trial Update: Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia [NA]

View source ↗

Summary

The document provides a clinical trial update for riboflavin-UVA induced collagen crosslinking as a treatment for corneal ectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia

Drugs mentioned

• Riboflavin ophthalmic solution (riboflavin)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Corneal Ectasia | NA | Status: UNKNOWN